Table 5.
Histopathological evaluation of the liver tissue of all groups.
| Parameters | Control | SFD | MUFAs | PUFAs | MCFAs | SCFAs |
|---|---|---|---|---|---|---|
| Inflammation | 0 | 2 | 1 | 0 | 1 | 1 |
| Necrosis | 0 | 3 | 0 | 0 | 1 | 0 |
| Ballooning | 0 | 3 | 1 | 1 | 2 | 1 |
| Bile duct proliferation | 0 | 1 | 0 | 0 | 2 | 0 |
| Fibrosis | 0 | 2 | 0 | 0 | 1 | 0 |
| Hemorrhage | 0 | 2 | 0 | 0 | 0 | 0 |
| Total scoring | 0 | 13a ± 0.87 | 2ab ± 0.31 | 1ab ± 0 | 7abcd ± 0.49 | 2abe ± 0.31 |
Data represent mean ± S.E. of observations from seven animals. a: significant from the control group. b: significant from long saturated fat (SFD) group, c: significant from monounsaturated (MUFAs) group, d: significant from polyunsaturated (PUFAs) group, e: significant from medium chain (MCFAs) group. significance: p < 0.05. SCFAs: short chain fatty acids.